Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
boston top stories
life sciences
national blog main
clinical trials
national top stories
san francisco blog main
san francisco top stories
boston
cancer
cancer drugs
covid-19
deals
fda
hepatitis b
ipo
medical device
new york blog main
new york top stories
startups
the column group
480 biomedical
abbvie
aligos therapeutics
allergan aesthetics
alzheimer's disease
amgen
arsenal medical
astrazeneca
athira pharma
attralus
baker brothers life sciences
benzodiazepine
biontech
biotech ipos
blackstone group
blepharitis
bob langer
boehringer ingelheim
What
way
4
×
debut
ipo
medicines
research
acquisitions
biggest
bio
biotech
biotechs
build
buy
cancer
cancer’s
central
ceo
cns
company
company’s
daniel
developing
disease
disorder
drug
drugs
dyne’s
emerged
frontiers
gilead
ipos
kept
known
late
leads
lyra
maps
markets
microbiome
million
moves
Language
unset
4
×
Current search:
way
×
unset
×
" boston blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
